What is the comparison between Famotidine (Famotidine) and Omeprazole (Omeprazole) for the treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Famotidine is generally less effective than Omeprazole for the treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients.

Comparison of Medications

  • Dosing: Famotidine is typically administered at a dose of 1 mg/kg/d, divided in 2 doses 1, while Omeprazole is administered at a dose of 0.7-3.3 mg/kg/d 1.
  • Efficacy: Proton pump inhibitors (PPIs) like Omeprazole have been shown to be more effective than histamine-2 receptor antagonists (H2RAs) like Famotidine in symptom relief and healing rates of erosive esophagitis 1.
  • Safety: Both medications are generally considered safe, but PPIs like Omeprazole may be associated with an increased risk of lower respiratory tract infections in infants 1, while H2RAs like Famotidine may be associated with tachyphylaxis and liver disease 1.

Treatment Considerations

  • Pediatric Indications: Omeprazole is approved for use in pediatric patients aged 1 year and older, while Famotidine is approved for use in pediatric patients aged 1-16 years 1.
  • Formulations: Omeprazole is available in a sprinkle formulation that can be administered with soft foods, while Famotidine is available in a cherry-banana-mint–flavored oral suspension 1.
  • Limitations of H2RAs: H2RAs like Famotidine have limitations, including rapid tachyphylaxis and decreased efficacy compared to PPIs 1.

From the FDA Drug Label

Famotidine tablets are indicated in adult and pediatric patients 40 kg and above for the treatment of: • symptomatic non-erosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Omeprazole delayed-release capsules are used: • for up to 4 weeks to treat heartburn and other symptoms that happen with gastroesophageal reflux disease (GERD). • for up to 8 weeks to treat gastroesophageal reflux disease (GERD) with acid-related damage to the lining of the esophagus [called erosive esophagitis (or EE) due to acid-mediated GERD]

The comparison between Famotidine and Omeprazole for the treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients is as follows:

  • Famotidine is indicated for pediatric patients 40 kg and above for the treatment of symptomatic non-erosive GERD and erosive esophagitis due to GERD.
  • Omeprazole is used in pediatric patients 2 to 16 years of age for the treatment of symptomatic GERD and erosive esophagitis due to acid-mediated GERD. There is no direct comparison of the efficacy and safety of Famotidine and Omeprazole in pediatric patients with GERD in the provided drug labels. 2 3

From the Research

Comparison of Famotidine and Omeprazole for GERD Treatment in Pediatric Patients

There are no studies provided that directly compare Famotidine and Omeprazole for the treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients. However, the following information can be gathered from the provided studies:

Efficacy of Omeprazole and Famotidine in Adults

  • Omeprazole has been shown to be more effective than Famotidine in reducing acid exposure and improving symptoms of GERD in adults 4, 5.
  • A study comparing the effects of Omeprazole and Famotidine on esophageal pH found that Omeprazole was more effective in reducing the percent of time with esophageal pH < 4 and the total number of GER episodes 4.
  • Another study found that Omeprazole provided quicker healing and greater relief from subjective symptoms than Famotidine in the treatment of reflux esophagitis 5.

Comparison of Acid-Suppressive Effects

  • A study comparing the acid-suppressive effects of Omeprazole and Famotidine found that Omeprazole had a more potent acid-suppressive effect than Famotidine, especially after repeated administration 6.
  • The study also found that the acid-suppressive effect of Omeprazole increased over time, while the effect of Famotidine decreased 6.

On-Demand Treatment of GERD

  • A study comparing the efficacy of Hydrotalcite and Famotidine in the on-demand treatment of GERD found that Hydrotalcite was more effective in relieving symptoms of heartburn than Famotidine, especially in the first 45 minutes after intake 7.
  • However, the study did not compare Omeprazole and Famotidine directly in the on-demand treatment of GERD.

Key Findings

  • Omeprazole has been shown to be more effective than Famotidine in reducing acid exposure and improving symptoms of GERD in adults.
  • The acid-suppressive effect of Omeprazole is more potent and longer-lasting than that of Famotidine.
  • There is no direct comparison between Omeprazole and Famotidine for the treatment of GERD in pediatric patients in the provided studies.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Research

Randomized comparative study of omeprazole and famotidine in reflux esophagitis.

Journal of gastroenterology and hepatology, 2002

7
Research

The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.

Medical science monitor : international medical journal of experimental and clinical research, 2007

Related Questions

What is the preferred treatment between Prilosec (omeprazole) and Pepcid (famotidine) for bisphosphonate-induced esophageal irritation?
Is famotidine (H2 receptor antagonist) a suitable alternative for a patient with esophageal narrowing who cannot tolerate omeprazole (proton pump inhibitor)?
What is the best approach for a 1-month-old female patient on Nutramigen (hypoallergenic formula) who is experiencing vomiting and has been prescribed Pepcid (Famotidine) and Nexium (Esomeprazole), but is having difficulty taking the medications?
What is the most appropriate next step in the workup of a 47-year-old man with worsening heartburn, previously treated with over-the-counter (OTC) medications, now requesting a prescription for stronger medication, such as omeprazole (proton pump inhibitor), with physical examination revealing tenderness at T2-T3?
Is it appropriate to increase the omeprazole (Proton Pump Inhibitor) dosage from 20mg to 40mg QAM (Every Morning) for a patient with worsening heartburn symptoms?
What is the dose of Calcitriol (Rocatrol) for a 2-year-old child weighing 12kg?
What is the earliest feature of iodine deficiency?
What is the milligram (mg) dosage of prednisolone per 5 milliliters (ml)?
What is the appropriate dose of Racecadotril for a 2-year-old child weighing 12 kilograms?
What are intraparotid lymph nodes?
Which of the following is a phase 1 reaction in metabolism: Acetylation, Sulfation, Glucuronidation, Methylation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question